Skip to main content
MedPathMedPath Home
Clinical Trials/NCT05118009
NCT05118009
Completed
Not Applicable

Artificial Intelligence Based Rapid Identification of ST-elevation Myocardial Infarction Using Electrocardiogram (ARISE)

National Defense Medical Center, Taiwan1 site in 1 country43,176 target enrollmentMay 1, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMyocardial Infarction, Acute

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myocardial Infarction, Acute
Sponsor
National Defense Medical Center, Taiwan
Enrollment
43176
Locations
1
Primary Endpoint
E2C (ECG to coronary angiography) time
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based supporting tool for improving the diagnosis and management of ST-elevation myocardial infarction.

Registry
clinicaltrials.gov
Start Date
May 1, 2022
End Date
May 31, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
National Defense Medical Center, Taiwan
Responsible Party
Principal Investigator
Principal Investigator

Chin Lin

Associate Professor

National Defense Medical Center, Taiwan

Eligibility Criteria

Inclusion Criteria

  • •Patients in emergency department or inpatient department.
  • •Patients recieved at least 1 ECG examination.

Exclusion Criteria

  • •The patients recieved ECG at the period of inactive AI-ECG system.

Outcomes

Primary Outcomes

E2C (ECG to coronary angiography) time

Time Frame: Within 6 hours

Time from ECG to activation of coronary angiography for STEMI patients.

Secondary Outcomes

  • Highest concentration of high-sensitivity cardiac troponin I(Within 3 days)
  • D2C (Door to coronary angiography) time(Within 6 hours)
  • Ejection fractrion(Within 3 days)
  • Highest concentration of creatine kinase(Within 3 days)
  • Length of hospitalization(Within 28 days)
  • Number of CAG event(Within 6 hours)
  • D2B (Door to Balloon Time) time(Within 6 hours)
  • E2B (ECG to primary percutaneous coronary intervention) time(Within 6 hours)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Artificial Intelligence-assisted Diagnosis and Prognostication in Low Ejection Fraction Using ElectrocardiogramsLeft Ventricular Systolic Dysfunction (Disorder)
NCT05117970National Defense Medical Center, Taiwan13,631
Completed
Not Applicable
Applying an Artificial Intelligence-Enabled Electrocardiographic System for Reducing MortalityCardiovascular DiseasesIntensity CareMorality
NCT05118035National Defense Medical Center, Taiwan15,965
Completed
Not Applicable
CARDIOLOGIST Trial: Artificial Intelligence Enabled Electrocardiogram for Atrial Fibrillation DetectionAtrial Fibrillation New Onset
NCT05127460National Defense Medical Center, Taiwan25,732
Completed
Not Applicable
ECG AI-Guided Screening for Low Ejection FractionAsymptomatic Left Ventricular Systolic Dysfunction (Disorder)Heart Failure
NCT04000087Mayo Clinic358
Completed
Not Applicable
Artificial Intelligence Identified Dyskalemia Using Electrocardiogram (AIDE)HyperkalemiaHypokalemia
NCT05118022National Defense Medical Center, Taiwan14,989